CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
about
TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis.Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progressionBiological functions and role of CCN1/Cyr61 in embryogenesis and tumorigenesis in the female reproductive system (Review).MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer.Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
P2860
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
@en
CYR61
@nl
type
label
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
@en
CYR61
@nl
prefLabel
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.
@en
CYR61
@nl
P2093
P2860
P356
P1433
P1476
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma
@en
P2093
Genbao Shao
Guanzhen Yu
Wannian Yang
P2860
P304
31067-31078
P356
10.18632/ONCOTARGET.8845
P407
P50
P577
2016-05-01T00:00:00Z